| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |